Posted by Michael Wonder on 11 Dec 2023
Cheaper medicines for breast cancer, small cell lung cancer, biliary tract cancer, juvenile idiopathic arthritis and Crohn's disease
11 December 2023 - From 1 December 2023, Australians with small cell lung cancer, biliary tract cancer, juvenile idiopathic arthritis and Crohn's disease will now have access to new treatment options through the PBS.
Pembrolizumab (Keytruda) will be expanded on the PBS to treat patients who have been diagnosed with early stage triple negative breast cancer.
